[ad_1]
July 14, Dr. Wanchai Sattayawutpong The Food and Drug Administration (FDA) announced that it has recalled Valsartan products in 22 countries around the world, due to its presence of carcinogens in the materials first used in the manufacture of drugs by Zhejiang Huahai Pharmaceuticals. Valsartan in the People's Republic of China. Has come to accept the error. In Thailand, there are 7 licensed manufacturers / importers or distributors of vasaram tablets in the Kingdom. A total of 14 recipes. There are only 2 authorized companies of Zhejiang Huahai Pharmaceuticals: Silom Medical Co., Ltd. and Unicun Co., Ltd., whose registered number is 5: 1. Silom Medical Co., Ltd. VALATAN 80 regimen 1A 9/54 (NG) (2) VALATAN 160 regimen No. 1A 10/54 (NG) 2. UNIVERSAL CO., LTD. 80 registration number of the drug 1A 4/60 (NG) (2) drug formula filed VALSARIN 160 No. 1A 5/60 (NG) (3) drug product VALSARIN 320 No. of registration 1A 6 / 60 (NG) of the Secretariat
. . Do not underestimate the insecurity associated with the use of drugs contaminated with carcinogens. There are measures to collect drugs. Registration form mentioned above. In all versions, the production returned from the market within 15 days, with the order of the licensee producing both drugs. Suspend the production and distribution of Valsar products. All records with the use of raw materials from the source are temporarily unavailable. Including the suspension of the distribution of pharmacy chemicals Valsar. The source of production and will continue to control the destruction. Also give import details. Valsar Chemicals sells each of these alternatives. Of all the production sites from 2015 to today, do not know by July 31, 2018. Also, early warning to the relevant agencies too.
Secretary General. At the end said. Do drug users check that the registration number of the drug is not used? If the registration number above. Return to the hospital or pharmacy to pay for the drugs. However, the contamination of this carcinogen. The process of raw materials. This is not a mistake in the manufacture of finished pharmaceuticals. The carcinogenicity of this carcinogen has been successfully treated. It can produce and sell drug products in lieu of the drug (Angiotensin II Receptor Blocker: ARB) is a blood pressure medication. A chronic disease that requires continuous medication. Patients who have already received vasaracid treatment for continuous treatment. No need to switch to other drugs for high blood pressure. You can still use the Valsar product. Registration number for other non-carcinogenic contaminants. I do not fear and I believe in the operation of the drug.Do not have to check the results of the registration of drugs in Thailand. If you have any problems, please report it to the public immediately.
[ad_2]
Source link